Regulation of monocyte cell fate by blood vessels mediated by Notch signalling by Gamrekelashvili, Jaba et al.
ARTICLE
Received 14 Mar 2016 | Accepted 8 Jul 2016 | Published 31 Aug 2016 | Updated 3 May 2017
Regulation of monocyte cell fate by blood vessels
mediated by Notch signalling
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A population of monocytes, known as Ly6Clo monocytes, patrol blood vessels by crawling
along the vascular endothelium. Here we show that endothelial cells control their origin
through Notch signalling. Using combinations of conditional genetic deletion strategies
and cell-fate tracking experiments we show that Notch2 regulates conversion of Ly6Chi
monocytes into Ly6Clo monocytes in vivo and in vitro, thereby regulating monocyte cell fate
under steady-state conditions. This process is controlled by Notch ligand delta-like 1 (Dll1)
expressed by a population of endothelial cells that constitute distinct vascular niches in the
bone marrow and spleen in vivo, while culture on recombinant DLL1 induces monocyte
conversion in vitro. Thus, blood vessels regulate monocyte conversion, a form of committed
myeloid cell fate regulation.
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M
onocytes are myeloid leukocytes that circulate through
blood vessels and patrol the vascular endothelium or
differentiate into mononuclear phagocytes. Mouse
monocytes consist of two distinct subsets that differ in behaviour
and function, which can be discriminated by expression of the
Ly6C antigen and CX3CR1 chemokine receptor in combination
with additional surface markers1,2. So called classical or Ly6Chi
monocytes are characterized by Ly6ChiCX3CR1lo and constitute
the more prevalent subset. They develop from the recently
identiﬁed common monocyte progenitor (cMoP)3, which in
turn is derived from the macrophage and dendritic cell
progenitor (MDP)4. Under steady-state conditions, Ly6Chi
monocytes circulate in the blood for short periods of time
and are the deﬁnitive precursors of certain tissue-resident
mononuclear phagocytes, for example in the gut, skin and
spleen2. When recruited to sites of inﬂammation through
interaction with subsets of activated vascular endothelial cells
(ECs), Ly6Chi monocytes give rise to macrophages and
dendritic cells, produce inﬂammatory mediators and orchestrate
the inﬂammatory response5–7. Based on functional and gene
expression studies, these monocytes correspond to a subset of
‘classical’ human monocytes.
There is a second subtype of monocytes that interacts
closely and constitutively with blood vessels. They display a
Ly6CloCX3CR1hi signature and hence are called Ly6Clo
monocytes. In the steady-state, Ly6Clo monocytes are long-lived
and remain mostly within blood vessels, where they crawl along
the luminal side of EC to monitor blood vessels and scavenge
microparticles8, a feature shared with the human CD16þ
monocyte subset9. After endothelial injury in the kidney,
Ly6Clo monocytes orchestrate EC necrosis and clearance10.
Moreover, Ly6Clo monocytes also mediate IgG-dependent
effector functions and are involved in immune complex-
mediated disease11,12. Ly6Clo monocytes were also suggested to
contribute to ischemic tissue repair5.
The cellular and molecular context of Ly6Clo monocyte
development is far from clear. Mice deﬁcient for the transcription
factor Nur77 (Nr4a1), an orphan nuclear receptor, show reduced
frequency and survival of Ly6Clo monocytes13. Recent ﬁndings
further suggest that in the steady state, Ly6Clo monocytes develop
from Ly6Chi monocytes2. Grafted MDP and cMoP sequentially
give rise to Ly6Chi monocytes followed by Ly6Clo monocytes3,6.
After adoptive transfer of Ly6Chi monocytes, Ly6Clo monocytes
are detected in the blood and bone marrow (BM) of recipients,
suggesting that Ly6Chi monocytes convert to Ly6Clo monocytes
in the circulation7,14. However, the tissues and molecular events
regulating monocyte conversion are unknown.
Notch signalling is a cell to cell contact-dependent signalling
pathway regulating cell fate decisions and inﬂammatory
responses in the immune system15. Activation of Notch
receptors (Notch1–4 in mammals) is controlled by membrane-
bound Notch ligands of the jagged (Jag) and Delta-like (Dll) gene
families, which show different Notch receptor binding afﬁnities
and tissue expression patterns, thereby controlling speciﬁc Notch
signalling outcomes16,17. The cellular interactions required for
Notch signalling often occur in local tissue microenvironments,
or niche, in the BM and spleen18. Vascular EC are a specialized
component of the niche that maintain and regulate stem cells and
their immune cell progeny by providing instructive paracrine
cues, known as angiocrine factors, in part through expression of
Notch ligands19. In the BM niche ECs trigger self-renewal and
repopulation of progenitor cells through Notch ligand Jag1
activating Notch1/Notch2 receptors in stem cells20,21. Similarly,
expansion and aggressiveness of B-cell lymphomas is induced by
an angiocrine mechanism involving endothelial Jag1 activating
Notch2 in malignant lymphoma cells22. Specialized vascular
niches are also found in secondary lymphoid organs, such as the
marginal zone (MZ) of the spleen, which constitutes an EC
interface between lymphoid follicles and the red pulp.
Development of MZ B cells and Esamþ dendritic cell in
the splenic niche is dependent on Notch ligand delta-like 1
(Dll1)-Notch2 signalling23–25. Monocytes, which are resident in
BM and spleen, express Notch1 and Notch2, and their cell fate is
inﬂuenced by DLL1 in vitro26.
Because of the intricate relationship of Ly6Clo monocytes with
EC we reasoned that blood vessels might be involved in monocyte
conversion through a Notch-dependent mechanism. We here
show that Notch2 signalling regulates conversion of Ly6Chi
monocytes into Ly6Clo monocytes, which is controlled by
Notch ligand Dll1 expressed by a population of EC present in
haematopoietic niches of the BM and spleen. Thus, blood vessels
regulate monocyte conversion, a form of committed myeloid cell
fate regulation.
Results
Monocyte populations and lineage relationships. Our aim was
to study the regulation of Ly6Clo monocytes. To discriminate
monocyte subsets and monocyte progenitor populations in mice
we concurrently characterized MDP, cMoP, Ly6Chi and Ly6Clo
monocytes in BM, spleen and peripheral blood (PB) with
common and discriminating markers of monocyte types based on
known expression proﬁles1–3,27. This approach was tested in
Cx3cr1GFP/þ reporter mice28, in which monocyte subsets
express distinct intensities of green ﬂuorescent protein (GFP),
but also in wild-type mice (Fig. 1a, Supplementary Fig. 1a,b and
Supplementary Table 1). In addition, monocyte subpopulations
were also validated in Nr4a1-GFP reporter mice29, which
demonstrated selective GFP expression in Ly6Clo monocytes
(Supplementary Fig. 2a,b). These studies conﬁrmed the
proto-typical ﬂow cytometry and gene expression proﬁles
reported for Ly6Chi and Ly6Clo monocytes (Fig. 1b,c)3.
Ly6Clo monocytes are reported to derive from Ly6Chi mono-
cytes under steady-state conditions, based on characteristic
changes of two markers, CX3CR1 and Ly6C, observed after
adoptive transfer of Ly6Chi monocytes7,14. To conﬁrm and extend
these ﬁndings we performed adoptive transfer studies with Ly6Chi
monocytes that were isolated from CD45.2þ Cx3cr1GFP/þ mice
and intravenously transferred into CD45.1þ -recipient mice
(Supplementary Fig. 3a,b). Cell fate of donor cells, distinguished
from recipient by expression of GFP and congenic CD45, was
analysed by ﬂow cytometry 2 and 4 days after transfer in BM and
spleen. When analysed by GFP and Ly6C expression, transferred
Ly6Chi monocytes progressively and uniformly switched to a
Ly6Clo monocyte phenotype displaying upregulation of GFP and
downregulation of Ly6C (Fig. 1d, Supplementary Fig. 3c). An
extended marker analysis demonstrated more complex phenotypic
changes involving the progressive acquisition of CD11c and
CD43 while maintaining low expression levels of major
histocompatibility complex (MHC)-II, consistent with conversion
into Ly6Clo monocytes. These changes occurred over a period of 4
days and were observed in BM and spleen (Fig. 1d). Thus, an
extended phenotypic analysis conﬁrms conversion of Ly6Chi
monocytes into Ly6Clo monocytes.
Notch2 regulates Ly6Clo monocytes in vivo. To evaluate a
potential role of Notch signalling in monocyte subset regulation
we sorted Ly6Chi and Ly6Clo monocytes from the BM and
analysed Notch-related gene-expression patterns. Compared with
Ly6Chi monocytes, Ly6Clo monocytes had lower expression of
Notch1 but comparable Notch2 expression in messenger RNA and
protein (Fig. 2a,e,f). Furthermore, Notch-regulated genes, Hey2
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and Hes1, were markedly induced in Ly6Clo monocytes,
indicating recent or on-going activation of Notch signalling in
this subset (Fig. 2a)3,30. We next wanted to conﬁrm these ﬁndings
on corresponding human monocyte subsets. Analysis of the
human CD16þ monocytes, which are considered equivalents of
mouse Ly6Clo monocytes, revealed higher expression of HES1
compared with the classical CD14þ monocytes (Fig. 2b).
We next asked whether Notch deﬁciency inﬂuences monocyte
subpopulations. To generate mice with conditional deletions of
Notch receptors in monocytes we crossed mice bearing ﬂoxed
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alleles of Notch1, Notch2 or Notch1/Notch2 (refs 17,31) with a
myeloid speciﬁc Cre-recombinase strain, LysMCre (ref. 32).
Strains were also back-crossed onto the Cx3cr1GFP/þ reporter
strain (Supplementary Table 2). This targeting strategy was
characterized in detail. LysM reporter analysis in LysM-eGFP
mice conﬁrmed low LysM promoter activity in progenitor
populations, but high promoter activity in Ly6Chi and Ly6Clo
monocytes (Supplementary Fig. 4a)33. In addition, crossing the
LysMCre strain to a Cre-dependent YFP reporter strain revealed
selective mature myeloid targeting, which was partial in Ly6Chi
monocytes, and more efﬁcient for Ly6Clo monocytes and
granulocytes (Fig. 2c, Supplementary Fig. 4b), conﬁrming
previous reports34.
Mice with conditional deletion of Notch2 (GFPþN2DMy) had
signiﬁcantly reduced absolute and relative numbers of Ly6Clo
monocytes in BM, PB and spleen (Fig. 2d, Supplementary
Fig. 5a). The defect was only observed in Ly6Clo monocytes, since
numbers of Ly6Chi monocytes, monocyte progenitor populations
and neutrophils were unaffected, and occurred independent of
the Gfp reporter allele or the Cre deleter allele (Fig. 2d and
Supplementary Fig. 5b–d). In contrast, mice with conditional
deletion of Notch1 showed no alteration in monocyte
subsets (Supplementary Fig. 5e), while combined deletion of
Notch1/Notch2 phenocopied the single Notch2 mutants
(Supplementary Fig. 5f). Altogether, these results demonstrate
that monocyte Notch2 controls Ly6Clo monocyte numbers,
suggesting a role in monocyte cell fate regulation.
To further investigate the selective reduction of Ly6Clo
monocytes we next characterized Notch2 receptor expression by
ﬂow cytometry in control mice and conditional mutants. Notch2
was robustly expressed in MDP, cMoP, Ly6Chi and Ly6Clo
monocytes in control mice (Fig. 2e,f). In GFPþN2DMy mice,
Notch2 expression was not affected in MDPs and cMoP, but
substantially reduced in Ly6Chi monocytes, consistent with partial
Cre expression and activity in this population (Fig. 2e,f,
Supplementary Fig. 4c and (ref. 34)). However, although Cre-
mediated targeting is more effective in Ly6Clo monocytes (Fig. 2c,
Supplementary Fig. 4b)34, most remaining Ly6Clo monocytes in
Notch2 mutant mice retained normal Notch2 receptor expression,
due to low expression of Cre (Fig. 2e,f and Supplementary Fig. 4c).
This suggests that the remaining Ly6Clo monocytes in these mice
develop from Notch2-expressing (Cre-negative) Ly6Chi monocytes
(Supplementary Fig. 4c). Consistent with this idea, increasing the
efﬁciency of Notch2 deletion in Ly6Chi monocytes, by using
Notch2f/f mice carrying two alleles of LysMCre, increased the rate of
Notch2 deletion in Ly6Chi monocytes but also lead to more
strongly reduced levels of Ly6Clo monocytes (Fig. 2g,h), while
Ly6Chi monocyte levels remained normal (Fig. 2g). Thus, loss of
Notch2 at the level of Ly6Chi monocytes is compatible with
generation of Ly6Chi monocytes, but incompatible with generation
of Ly6Clo monocytes. Indeed, plotting Notch2 receptor levels on
Ly6C monocytes against the frequency of Ly6Clo monocytes
revealed that loss of Notch2 on Ly6Chi monocytes correlated
strongly with loss of Ly6Clo monocytes (Fig. 2h). This also
suggested that the fate of Ly6Clo monocytes is linked to Ly6Chi
monocytes through Notch2.
We next wanted to test the effects of a more selective deletion
of Notch 2 within the Ly6Clo population. To this end we used a
conditional CD11c-Cre transgenic approach to delete Notch2 at
early stages of Ly6Clo monocyte development, since CD11c is
selectively upregulated in Ly6Clo monocytes at early stages of
conversion (Fig. 1d, Fig. 5a). Loss of Notch2 partially reduced the
number of Ly6Clo monocytes without affecting Ly6Chi monocytes
(Fig. 2i, Supplementary Fig. 4d). Altogether, this demonstrates a
requirement for Notch2 in the generation and maintenance of
Ly6Clo monocytes.
Physiologic consequences of monocyte Notch2 deﬁciency. To
study the consequences of Notch2 loss of function for
monocyte patrolling behaviour in more detail we performed
intravital microscopy of the cremaster muscle8,35. Under
steady-state conditions, the number of rolling and adherent
Ly6Clo monocytes was greatly reduced in GFPþN2DMy mice,
which conﬁrmed the results obtained by ﬂow cytometry
(Fig. 3a,b). Furthermore, while TNF-a treatment increased the
rolling and adherence of Ly6Clo monocytes in control mice, this
response was blunted in GFPþN2DMy mice (Fig. 3a,b),
demonstrating a profound impairment of the Ly6Clo monocyte
subpopulation with Notch2 loss of function. This result also ruled
out the possibility that mutant Ly6Clo monocytes preferentially
localize to blood vessel walls. In addition, the reduction of Ly6Clo
monocytes in Notch2 mutant mice was accompanied by
accumulation of an atypical cell population expressing high
levels of MHC-II and CCR2 but low levels of CD11c, CD43 and
CD11a (Fig. 3c–e), a phenotype not resembling a previously
described MHC-IIþ monocyte population36.
Notch2 regulates Ly6Chi monocyte conversion in vivo. Ly6Clo
monocyte deﬁciency could be due to increased cell death, as was
shown in mice deﬁcient for the transcription factor Nr4a1, which
controls Ly6Clo monocyte numbers in part by regulating
monocyte apoptosis13. We, therefore, tested the hypothesis that
Notch2 regulates monocyte survival. However, neither the
fraction of apoptotic cells, nor the fraction of dead cells was
altered in each of the monocytes subsets in BM, PB or spleen in
conditional Notch2 mutants (Fig. 4a,b).
To address the question whether conversion of Ly6Chi
monocytes depends on Notch2 we isolated Ly6Chi monocytes
from Cx3cr1GFP/þ control mice or conditional Notch2 mutants
and analysed the cell fate after adoptive transfer into CD45.1þ
congenic wild-type recipients. Four days after transfer the
majority of recovered donor cells from control donors had
converted into Ly6Clo monocytes, while few remained Ly6Chi
monocytes. After transfer of cells from conditional mutants,
however, the fraction of donor cells that had converted into
Figure 1 | Identiﬁcation of monocyte subsets and lineage relationships. (a) Monocyte subpopulation analysis strategy in PB of Cx3cr1GFP/þ mice. Initially
cells were identiﬁed based on FSC and SSC characteristics. After exclusion of doublets (on the basis of SSC-W, SSC-A) LinCD11bþ cells were gated from
live (7AAD) CD45þ gate and CD117þ and GFP populations were excluded. Remaining cells were divided into Ly6ChiF4/80lo/ (R2) and
Ly6Clo/F4/80lo (R3) subsets. Ly6Chi monocytes were deﬁned from R2 as CD11cMHC-IIlo/ (red) and Ly6Clo monocytes from R3—as CD11clo
MHC-IIlo/ (blue) cells. (b) Ly6Clo monocytes are smaller, contain fewer granules than Ly6Chi monocytes and show CD11cloGFPhiCD43þ phenotype.
Numbers are mean±s.e.m. (c) Quantitative reverse transcription–PCR analysis performed in sorted monocyte subsets from BM of Cx3cr1GFP/þ mice.
Change relative to expression in Ly6Chi cells is shown (n¼ 3/6). Error bars represent s.e.m. *Po0.05, **Po0.01, ***Po0.001; Student’s t-test.
(d) Dynamics of Ly6Clo monocyte development. BM CD45.2þCD11bþGFPþ Ly6Chi monocytes were transferred into CD45.1þ recipients and their
conversion into Ly6Clo monocytes were followed in vivo. Flow cytometry analysis of recipient spleen and BM is depicted. Transferred cells are black and for
comparison, recipient CD45.1þ (ﬁrst row), CD45.1þCD11bþ (second row), CD45.1þCD11bþLy6Chi (third row) cells or CD45.1þCD11bþ Ly6ChiF4/80lo
monocytes (fourth and ﬁfth rows) are shown in blue (representative of two experiments).
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Figure 2 | Conditional deletion of Notch2 impairs Ly6Clo monocyte development. (a) Quantitative reverse transcription–PCR analysis in sorted monocyte
subsets from BM of Cx3cr1GFP/þ mice; (n¼ 6, pooled from three experiments). (b) HES1 expression in human CD14þ (classical) or CD16þ (non-classical)
monocytes from two donors. (c) Quantiﬁcation of YFPþ cells in myeloid cells from LysMCreRosaYFP mice as a hallmark of Cre activity. Data are pooled from two
experiments with three mice in each group. (d) Flow cytometry of myeloid cell subpopulations in mice with conditional deletion of Notch2. Absolute number of
cells per mg BM, per ml blood or per spleen is shown (top). Relative frequency of each subpopulation from live cell gate is shown (bottom). Data are pooled
from three experiments with 11/8 mice in each group. (e) Notch2 expression in myeloid cell subpopulations from BM of GFPþNotch2DMy mice. (f) Notch2
expression in Ly6Chi and Ly6Clo monocyte subpopulations isolated from BM. Littermate controls are shown for comparison. (g) Quantiﬁcation of monocyte
subpopulations in mice with conditional deletion of Notch2 and expressing two alleles of LysMCre. Absolute number of cells per mg BM, per ml blood or per
spleen is shown (top). Relative frequency of each subpopulation from live cell gate is shown (bottom). Data are pooled from three experiments with 12/7 mice
in each group. (h) Correlation of Notch2þ Ly6Chi monocyte frequency with frequency of Ly6Clo monocytes. Frequency of Notch2þLy6Chi monocytes shows
strong positive correlation with Ly6Clo monocyte numbers (n¼ 28). (i) Quantiﬁcation of monocyte subpopulations in Notch2DCD11cmice. Data are pooled from
two experiments with four mice in each group. (a,c,d,g,i) *Po0.05, **Po0.01, ***Po0.001; Student’s t-test. Error bars represent s.e.m.
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Ly6Clo monocytes was strongly reduced, while the fraction of
recovered Ly6Chi monocytes was signiﬁcantly increased
(Fig. 4c,d, Supplementary Fig. 6). Similar results were obtained
in experiments when peripheral Ly6Chi monocytes retrieved from
PB and spleen were used for transfer (Supplementary Fig. 7),
which also ruled out development of Ly6Clo monocytes from
contaminating BM precursors. Thus, Ly6Chi monocytes deﬁcient
for Notch2 show impaired conversion into Ly6Clo monocytes,
demonstrating regulation of monocyte cell fate by Notch2.
Dll1-Notch2 axis controls monocyte conversion in vitro. Notch
receptors are differentially engaged by Notch ligands, and Notch2
is a preferred target of DLL1 (ref. 24). To deﬁne the Notch
signalling components regulating monocyte conversion, and to
provide proof-of-principle that Notch activation is sufﬁcient
to regulate this process, we established an in vitro culture system
to mimic the initial steps during monocyte conversion under
deﬁned conditions. We sorted Ly6Chi monocytes from BM of
Cx3cr1GFP/þ mice (Fig. 5a day 0) and cultured them in the
presence of immobilized recombinant DLL1 protein, or control
conditions (Fig. 5a and Supplementary Fig. 8). In culture,
downregulation of Ly6C and upregulation of GFP occurred in all
conditions over time, while cells remained uniformly CD115þ
(Fig. 5a, Supplementary Fig. 8b). However, conversion of Ly6Chi
into Ly6Clo monocyte-like cells, detected by upregulation of
CD43 and CD11c in MHC-IIlo/ cells, occurred to a signiﬁcantly
greater extent on DLL1 than in control cultures (Fig. 5a,b).
Furthermore, in gene expression proﬁling, cells cultured on DLL1
showed signiﬁcantly higher levels of Nr4a1 and Pou2f2 and sig-
niﬁcantly lower levels of Slfn5 compared with control culture
(Fig. 5c), similar to a Ly6Clo monocyte phenotype3.
The effect was speciﬁc for DLL1, since culture of Ly6Chi
monocytes on another Notch ligand, JAG1, was much less effective
in generating Ly6Clo monocyte-like cells, as were control
conditions (Fig. 5d,e). Furthermore, DLL1-induced monocyte
conversion was impaired by incubation with a g-secretase
inhibitor, N-(N-(3,5-diﬂuorophenacetyl)-L-alanyl)-S-phenylgly-
cine t-butyl ester (DAPT), which blocks the generation of the
active intracellular Notch domain37, thus indicating that
DLL1-induced Notch receptor cleavage is required for this
process (Fig. 6a,b). Importantly, DLL1-induced monocyte
conversion was also severely impaired in Ly6Chi monocytes from
Notch2 conditional mutants when compared with controls
(Fig. 6c,d). These results demonstrate that a speciﬁc Dll1-Notch2
signalling axis controls conversion of Ly6Chi monocytes into
Ly6Clo monocyte-like cells.
Dll1 is expressed in distinct endothelial niches. We wanted to
corroborate the speciﬁc function of Dll1 for Ly6Clo monocyte
development in vivo. In the adult mouse, Dll1 is selectively
expressed in vascular endothelium of arteries, but not veins or
capillaries, and in EC in the MZ of the spleen24,37. We ﬁrst
characterized in more detail Dll1 expression in the two principle
haematopoietic compartments, BM and spleen, using genetic
reporter mice or immunostaining. In Dll1þ /lacZ reporter mice, in
which one allele of Dll1 has been replaced by lacZ, speciﬁc
reporter staining was observed in the splenic MZ, but not in the
central artery of the splenic follicle (Fig. 7a). Immunoﬂuorescence
staining against CD31 and DLL1 and confocal microscopy
revealed DLL1 expression in EC of the MZ and conﬁrmed its
absence in the central artery of the follicle (Fig. 7b). Interestingly,
DLL1 staining in Cx3cr1GFP/þ reporter mice demonstrated a
c
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close spatial relationship between DLL1 expression and GFPþ
cell populations in the MZ, suggesting a potential niche function
(Fig. 7c). Co-staining with Ly6C or CD43 identiﬁed both
monocyte subsets within the CD31þ and DLL1þ MZ area,
while large GFPþ macrophages reside in the borders of the MZ
(Fig. 7d,e and Supplementary Fig. 9a,b). Furthermore, speciﬁc
Dll1-reporter staining in Dll1þ /lacZ mice was also observed in the
BM, which appeared in a reticular pattern in the diaphysal area of
the BM cavity, suggesting a vascular pattern (Fig. 7f). More
importantly, the defect in Ly6Clo monocytes observed in Notch2
conditional mutants was recapitulated in haploinsufﬁcient Dll1
mutant mice (Fig. 7g). This demonstrates a critical role for Dll1 in
the regulation of Ly6Clo monocytes in vivo, and emphasizes the
importance of a Dll1-Notch2 axis in the control of Ly6Clo
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monocyte development. Furthermore, these observations also
suggest that distinct Dll1þ EC might form specialized niches for
the generation of Ly6Clo monocytes.
Endothelial Dll1 controls Ly6Clo monocyte development. To
test the hypothesis that endothelial Dll1 regulates Ly6Clo monocyte
development we employed an endothelial-speciﬁc and inducible
deletion strategy using the Cdh5(PAC)-CreERT2 strain, which
shows EC-speciﬁc Cre activity in peripheral vessels and the BM
cavity16,38. We ﬁrst conﬁrmed pan-endothelial, but EC-speciﬁc,
targeting by generating Cre-dependent lacZ-reporter mice
(lacZiEC), which demonstrated inducible EC staining in arteries,
veins and capillaries after tamoxifen treatment, but also
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demonstrated Cre activity in splenic MZ EC and BM EC (Fig. 8a,
Supplementary Fig. 9c). Employing a conditional allele of Dll1
(ref. 23) we next generated endothelial-speciﬁc and inducible
Dll1 mutant mice (Dll1iDEC) and conﬁrmed Cre-dependent
recombination and deletion of the conditional Dll1 allele after a
pulse of tamoxifen (Supplementary Fig. 9d,e). In controlled
experiments (Supplementary Fig. 7f,g), endothelial deletion of
Dll1 resulted in the selective reduction of Ly6Clo monocytes, while
Ly6Chi monocytes and monocyte progenitors where unchanged
compared with control (Fig. 8b). These data demonstrate that
endothelial Dll1 regulates Ly6Clo monocytes in vivo.
Although our data clearly indicated the importance of
endothelial Dll1 for monocyte conversion, given the selective
expression of Dll1 in two distinct endothelial domains, arteries
and the haematopoietic compartment (BM and spleen), the
identity of the endothelial domain mediating monocyte
conversion remained unclear and could not be addressed with
our pan-endothelial deletion strategy. We, therefore, generated
mice with inducible, but arterial EC-speciﬁc deletion of Dll1, by
crossing the ﬂoxed allele of Dll1 to Bmx(PAC)-CreERT2 mice
(Dll1iDaEC)39. We conﬁrmed the arterial EC-speciﬁc Cre activity
in a Cre-dependent lacZ-reporter strain (lacZiaEC), which
demonstrated speciﬁc EC staining in aorta, peripheral arteries
and central arteries of the splenic follicles, while MZ EC were not
targeted, thus providing a tool to address the contribution of
arterial EC to monocyte conversion (Supplementary Fig. 10a).
We induced Dll1 deletion in arterial EC, which resulted in
Cre-dependent recombination of the conditional Dll1 allele
(Supplementary Fig. 10b). In contrast to pan-endothelial
deletion of Dll1, arterial EC-speciﬁc deletion of Dll1 did not
affect relative or absolute numbers of Ly6Clo monocytes (Fig. 8c),
suggesting that Dll1 expressed in endothelial niches in the MZ or
BM, and not in arterial endothelium, regulates monocyte
conversion.
To further investigate the speciﬁcity of Dll1 effects on Ly6Clo
monocytes we mated the pan-endothelial and inducible
Cre-transgenic strain to conditional alleles of the related Notch
ligand Dll4 (refs 38,40). In contrast to deletion of Dll1, deletion of
Dll4 did not lead to alterations in Ly6Clo monocytes, or any other
myeloid subset (Fig. 8d), which demonstrates speciﬁc effects of
Dll1 in the regulation of Ly6Clo monocytes.
To provide proof-of-principle that EC populations from the
haematopoietic compartment regulate monocyte conversion
we established an in vitro co-culture system. CD144þ ECs
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were sorted from splenic tissue digests and cultured with
Ly6Chi monocytes from Cx3cr1GFP/þ reporter mice. We also
conﬁrmed Dll1 expression in this EC population (Fig. 8e).
Compared with monocytes cultured alone, conversion of Ly6Chi
monocytes into Ly6Clo monocyte-like cells was signiﬁcantly
increased on splenic EC, an effect that persisted over time
(Fig. 8f,g). Altogether, these results suggest that distinct
endothelial niches in the haematopoietic compartments regulate
conversion of Ly6Chi monocytes into Ly6Clo monocytes via the
Dll1-Notch2 axis.
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Discussion
We here deﬁne the molecular and cellular context that regulates
monocyte conversion. Taken together, our results show that
Notch2 regulates conversion of Ly6Chi monocytes into Ly6Clo
monocytes, thereby regulating a speciﬁc developmental step
in monocyte cell fate under steady-state conditions. This
process is controlled speciﬁcally by Notch ligand Dll1 expressed
by a population of EC that constitute distinct vascular niches in
the BM and spleen. Thus, blood vessels regulate monocyte
conversion, as a form of developmental cell fate regulation.
The origin and regulation of Ly6Clo monocytes is still poorly
understood. Recent ﬁndings have suggested that Ly6Clo
monocytes develop from Ly6Chi monocytes. Adoptive transfer
of cMoP leads to the sequential appearance of Ly6Chi monocytes
followed by Ly6Clo monocytes3. Furthermore, Jung and
colleagues have provided direct evidence that Ly6Clo monocytes
derive from Ly6Chi monocytes by adoptive transfer
experiments7,14. Our experiments demonstrating monocyte
conversion with isolated Ly6Chi monocytes in vivo, and
recapitulation of it in vitro, clearly support the notion of
monocyte conversion as a mechanism regulating development
of Ly6Clo monocytes. However, while our data provide
evidence for and insights into the mechanism of monocyte
conversion, our ﬁndings do not exclude the existence of
additional mechanisms to generate Ly6Clo monocytes, for
example from progenitor cells, as has been recently suggested41.
So far, speciﬁc molecular or cellular regulators of monocyte
conversion have remained elusive, and it has been speculated that
monocyte conversion occurs spontaneously in the circulation2,14.
Our data demonstrating a requirement for the Dll1-Notch2
signalling axis for the conversion of Ly6Chi monocytes into
Ly6Clo monocytes not only provides clear evidence for the
regulated nature of monocyte conversion, but also shows that this
process is under control of blood vessels through Notch ligand
Dll1. The fact that conditional deletion of Dll4 has no impact on
Ly6Clo monocytes further emphasizes the speciﬁc nature of Dll1
actions. Although the precise location of monocyte conversion
remains unknown, our data clearly demonstrate the existence,
and functional importance, of distinct Dll1-expressing vascular
niches in BM and spleen. This suggests that monocyte conversion
happens, or is at least initiated, in these vascular niches under
steady-state conditions. This is further supported by the fact that
co-cultured EC from these niches promote monocyte conversion,
while our in vivo data from mice with arterial-speciﬁc Dll1
deletion exclude the participation of arterial ECs in this process.
However, given the dynamic nature of endothelial responses, it is
conceivable that in certain situations, such as inﬂammation, the
location, composition and extent of vascular niches might change,
which, in turn, might inﬂuence monocyte conversion rates.
Recently, the instructive function of the vascular niche for
self-renewal and regenerative capacity of HSCs has been deﬁned,
which, in part, is mediated by endothelial-speciﬁc expression of
Notch ligand Jag1 (refs 20,21). Our ﬁnding that monocyte
conversion is regulated by ECs extends the spectrum of
niche regulation towards more committed steps of myeloid cell
development and further supports the importance of the vascular
niche in regulating cell fate. On the other hand, the ﬁnding that
monocyte conversion is speciﬁcally regulated by vascular Dll1
underlines the ligand-speciﬁc nature of Notch signalling events in
different locations16.
Our data also suggest that Notch2 expressed in monocytes is
directly involved in regulation of Ly6Clo monocyte cell fate in
response to Dll1. Several lines of evidence support this
conclusion. First, Notch2 was required for monocyte conversion
in experiments using isolated Ly6Chi monocytes in vivo and
in vitro. Second, when Notch2 was targeted on Ly6Chi monocytes
in vivo we found that the extent of Notch2 loss-of-function in
Ly6Chi monocytes is related to the loss of Ly6Clo monocytes,
while Ly6Chi monocyte numbers are not affected by Notch2
deletion. On the other hand, targeting of Notch2 in Ly6Clo
monocytes also resulted in selective deletion of Ly6Clo
monocytes. Together, this demonstrates a requirement for
monocyte Notch2 in the generation, as well as maintenance of
Ly6Clo monocytes. Finally, Notch2 loss-of-function lead to the
appearance of an atypical monocyte population negative for
CD11c and CD43 but expressing high levels of MHC-II and
CCR2. These ﬁndings suggest a model in which Notch2
regulates Ly6Clo monocyte cell fate: active Notch2 signalling
mediates conversion into Ly6Clo monocytes, while defective
Notch2 signalling leads to MHC-IIhi atypical monocytes. While
the role and relevance of this atypical monocyte population
observed in conditional mutants is currently unclear, it is
important to note that, using different gating strategies and
experimental approaches, subpopulations of MHC-II-expressing
monocytes have recently been described, which acquire antigen
for carriage to lymph nodes36.
Currently, the molecular effectors of Notch2 in monocytes are
unknown. Interestingly, the transcription factor Nr4a1, an orphan
nuclear receptor, regulates the survival of Ly6Clo monocytes13.
Although a role of Nr4a1 in monocyte conversion has not been
investigated, mice with general or BM-restricted inactivation of
Nr4a1 showed reduced Ly6Clo monocytes numbers and increased
rates of apoptosis. Although we did not observe a cell death
phenotype in Notch2 mutant mice, we found DLL1-dependent
regulation of Nr4a1 in vitro. Clearly, the molecular regulation of
monocyte conversion requires further study.
Our study also describes the ﬁrst steps towards an approach to
recapitulate monocyte cell fate ex vivo. This might provide a
setting to study and understand the molecular events driving
monocyte conversion under deﬁned conditions.
Methods
Mice. Mouse strains used in the study are listed in Supplementary Table 2.
Cx3cr1GFP/þ mice28 (kindly provided by Steffen Jung), LysMCre mice32, Dll1þ /lacZ
mice42 (kindly provided by Achim Gossler), Notch1lox/lox and Notch2lox/lox mice17,
Cdh5(PAC)-CreERT2 mice43, Bmx(PAC)-CreERT2 mice44, Dll1lox/lox mice23,
Dll4lox/lox mice45, N2DCD11c mice46, N1N2DCD11c mice47, Nr4a1-GFP mice29,
LysM-eGFP mice33, LysMCreRosaYFP mice48 have been described. Gt(ROSA)26Sor
mice carrying Cre-inducible lacZ alleles were obtained from The Jackson
Laboratories, B6.SJL-PtprcaPepcb/BoyJ (CD45.1þ ) mice from Charles River. Mice
were housed under speciﬁc pathogen free conditions in the animal facility of
Hannover Medical School unless otherwise indicated. Nr4a1-GFP, LysM-eGFP and
LysMCreRosaYFP mice were housed in IPEC, Munich, Germany; N2DCD11c mice in
WUSTL, St Louis, MO, USA; N1N2DCD11c mice in Tokushima University,
Tokushima, Japan and Cdh5(PAC)-CreERT2 Dll4lox/lox mice in MPI Munster,
Germany. All experiments were performed with 8–12-weeks-old mice and age and
sex matched littermate controls with approval of the local animal welfare boards
(LAVES Lower Saxony, Animal Studies Committee at Washington University in St
Louis, Animal Research Committee of Tokushima University, North Rhine
Westphalia Animal Ethics Committee and Local Animal Committee of District
Government of Upper Bavaria).
Tissue and cell preparation. For single cell suspension mice were killed and
spleen, BM and blood were collected. Erythrocytes were removed by red blood cell
lysis buffer (Biolegend) or by density centrifugation using Histopaque 1083 (Sigma-
Aldrich). After extensive washing cells were resuspended in PBS containing 10% FCS
and 2mM EDTA kept on ice, stained and used for ﬂow cytometry or for sorting.
Flow cytometry and cell sorting. Non-speciﬁc binding of antibodies by
Fc-receptors was blocked with anti-mouse CD16/CD32 (TruStain fcX from
Biolegend) in single cell suspensions prepared from spleen, PB or BM. After
subsequent washing step cells were labelled with primary and secondary antibodies
or streptavidin-ﬂuorochrome conjugates (Supplementary Table 3) and used for
ﬂow cytometry analysis (LSR-II, BD Biosciences) or sorting (FACSAria; BD
Biosciences or MoFlo XDP; Beckman Coulter). Data were analysed by FlowJo
software (Treestar). Initially cells were identiﬁed based on forward scatter (FSC)
and side scatter (SSC) characteristics. After exclusion of doublets (on the basis of
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SSC-W, SSC-A), relative frequency of each subpopulation from live cell gate or
absolute number of each subset (calculated from live cell gate and normalized on
mg BM, ml PB or spleen) were determined and are shown in the graphs as
mean±s.e.m., unless otherwise stated.
In vitro conversion studies. Ninety-six-well ﬂat bottom plates were coated at room
temperature for 3 h with IgG-Fc, JAG1-Fc or DLL1-Fc ligands (all from R&D)
reconstituted in PBS. Sorted BM Ly6Chi monocytes were cultured in coated plates in
the presence of M-CSF (10 ngml 1), thrombopoietin (TPO, 20ngml 1), stem cell
factor (SCF, 10 ngml 1), insulin-like growth factor (IGF)-II (20 ngml 1), ﬁbroblast
growth factor (FGF)-I (10 ngml 1) (all from Peprotech) and Heparin (25Uml 1)
at 37 C for 24 or 48 h. In experiments where the effect of Notch inhibition on
conversion process was assessed, 6mM of g-secretase inhibitor, DAPT or dime-
thylsulphoxide (DMSO) was applied to the cells prior to and 24h after culture. In
separate experiments BM Ly6Chi monocytes were co-cultured with sorted splenic
CD144þGFPCD11b EC. One or 2 days after culture, cells were harvested,
stained and subjected to ﬂow cytometry. Frequency of Ly6Clo monocyte-like cells
(CD11bþGFPþLy6Clo/CD11cloMHC-IIlo/CD43þ ) in total live CD11bþ
GFPþ cells served as an indicator of conversion efﬁciency and is shown in the
graphs.
Adoptive cell transfer experiments. CD11bþLy6ChiGFPþ monocytes were
sorted from BM and injected into CD45.1þ recipients intravenously (i.v.). Four
days after transfer spleen, PB and BM were collected and single cell suspension was
prepared. After blocking of Fc receptors using anti-mouse CD16/CD32 (TruStain
fcX from Biolegend) cells were labelled with biotin-conjugated anti-CD45.1 anti-
body, anti-biotin magnetic beads and enriched on LD columns (Miltenyi Biotec)
according to the manufacturer’s instructions. CD45.1 negative fraction was col-
lected, stained and analysed by ﬂow cytometry. Ly6Clo monocytes (CD11bþ
GFPþLy6Clo/F4/80loCD11cloMHC-IIlo/ cells) were quantiﬁed in spleen, BM
and PB as relative frequency of total donor derived CD45.2þCD11bþGFPþ cells.
Human monocyte isolation. Human monocytes were isolated from the blood of
healthy individuals as approved by the ethical committee of Hannover Medical
School. Written consent was obtained before blood collection. Cells were puriﬁed
using CD16þ monocyte isolation kit (Miltenyi Biotec) according to the
manufacturer’s instruction. CD14þ monocytes were retrieved in subsequent
puriﬁcation step from CD16neg fraction using CD14 microbeads.
Immunohistochemistry and immunoﬂuorescence. Immunohistochemistry,
b-galactosidase and immunoﬂuorescence staining in mice were performed with
modiﬁcations from previous descriptions37,49. Mice were euthanized; tibiae, spleen,
heart, aorta and muscles were isolated and ﬁxed in 4% paraformaldehyde (PFA).
Bones were decalciﬁed in 0.5M EDTA solution at 4 C for 48 h, cryopreserved in
sucrose and embedded in Tissue-tek O.C.T. compound (Sakura, Germany). All the
other organs were cryoprotected in sucrose and embedded in Tissue-tek O.C.T.
compound without decalciﬁcation procedure. b-galactosidase staining was
performed at 37 C on PFA ﬁxed tissues. Slides were counterstained with eosin,
mounted in mounting medium and analysed with Olympus IX71 microscope.
For immunoﬂuorescence and confocal laser scanning microscopy tissue sections
were stained using anti-DLL1 (Biolegend), anti-CD31, anti-CD43 (both from
BD Biosciences, Germany), anti-Ly6C (Biolegend) and appropriate ﬂuorescence-
conjugated secondary antibodies (Supplementary Table 3). 4,6-Diamidino-2-
phenylindole (Invitrogen, Germany) was used for counterstaining of nuclei and
slides were mounted in DAKO ﬂuorescence mounting medium (Dako, Denmark).
Images were acquired using Leica TCS SP2 AOBS (Leica Microsystems, Germany)
confocal microscope or Zeiss Observer Z1 ﬂuorescence microscope (Zeiss,
Germany), respectively.
Intravital microscopy. To visualize monocytes in the microcirculation the
cremaster muscle of male GFPþ ctrl and GFPþN2DMy mice was exposed and
transient and adhesive interactions were recorded. To this end an Olympus BX51
microscope equipped with a Hamamatsu 9100-02 EMCCD camera (Hamamatsu
Photonics) and a  40 water-dipping objective was employed. In each cremaster
10 ﬁelds of view were recorded for 30 s and the number of adherent cells and the
rolling ﬂux (rolling monocytes passing a perpendicular line placed across the
observed vessel) from each ﬁeld were quantiﬁed. Subsequent to recordings at
baseline, mice were injected via a jugular vein catheter with a single dose of TNF-a
(250 ng) and recordings were repeated after 60min.
Quantitative real-time PCR analysis. Splenic ECs, as well as splenic or BM
monocytes were isolated by cell sorting and total RNA was puriﬁed using
Nucleospin RNA II kit (Macherey Nagel). After purity and quality check, RNA was
transcribed into complementary DNA employing complementary DNA synthesis
kit (Invitrogen) according to the manufacturer’s instructions. Quantitative
real-time PCR was performed using speciﬁc primers (Supplementary Table 4) and
FastStart Essential DNA Green Master on a LightCycler 96 system from
Roche according to the manufacturer’s instructions, for normalization. Expression
of each speciﬁc gene was normalized to expression of Rps9 and calculated by the
comparative CT (2DDCT) method50.
In vivo targeting of EC and PCR analysis. Five to 6-weeks-old mice expressing
EC-speciﬁc inducible Cre recombinase and Cre-negative littermate controls were
treated with 500 mg tamoxifen for 5 consecutive days intraperitoneally (i.p.). Mice
were killed after 4 weeks. Efﬁciency of Cre-dependent gene deletion was monitored
by PCR and agarose gel-electrophoresis as described23.
Statistical analysis. Results are expressed as mean±s.e.m.. N numbers are
biological replicates of experiments performed at least three times unless otherwise
indicated. Signiﬁcance of differences was calculated using unpaired, two-tailed
Student’s t-test with conﬁdence interval of 95%. For comparison of multiple
experimental groups one-way analysis of variance (ANOVA) was used and
Bonferroni’s multiple-comparison test was performed when the overall P value
was o0.05. Data from intravital microscopy were analysed using two-way
ANOVA and Bonferroni’s post-test. P values of less than 0.05 were considered to
be signiﬁcant.
Data availability. The authors declare that all the relevant data are available upon
request.
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